Biogen Idec Alzheimer’s Drug to Receive Late-Stage Study by REUTERS

By REUTERS

The company said the drug reduced levels of plaque in the brain and significantly improved cognition in a small early-stage study.

Published: December 3, 2014 at 12:00AM

from NYT Business Day http://ift.tt/1vIrz1s

from WordPress http://ift.tt/1Bbn5DT

via Hadi Aboukhater